Acorah Software Products - Accounts Production16.3.350truetrue30 September 20241 October 2023false1 October 202430 September 202530 September 202508704252Dr Charmaine JoosteMr Daniel Faucittiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure087042522024-09-30087042522025-09-30087042522024-10-012025-09-3008704252frs-bus:CompanyLimitedByGuarantee2024-10-012025-09-3008704252frs-bus:FilletedAccounts2024-10-012025-09-3008704252frs-bus:SmallEntities2024-10-012025-09-3008704252frs-bus:EntityHasNeverTraded2024-10-012025-09-3008704252frs-bus:AuditExempt-NoAccountantsReport2024-10-012025-09-3008704252frs-bus:SmallCompaniesRegimeForAccounts2024-10-012025-09-3008704252frs-bus:Director12024-10-012025-09-3008704252frs-bus:Director22024-10-012025-09-3008704252frs-countries:EnglandWales2024-10-012025-09-30087042522023-09-30087042522024-09-30087042522023-10-012024-09-30
Registered number: 08704252
London International Inflammation Foundation Limited
Dormant Financial Statements
For The Year Ended 30 September 2025
Goringe Accountants Ltd
1650 Arlington Business Park
Theale
Reading
Berkshire
RG7 4SA
London International Inflammation Foundation Limited
London International Inflammation Foundation Limited
Balance Sheet
As At 30 September 2025
Balance Sheet
Registered number: 08704252
2025
2024
Notes
£
£
£
£
TOTAL ASSETS LESS CURRENT LIABILITIES
-
-
NET ASSETS
-
-
MEMBERS' FUNDS
-
-
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income and Expenditure Account.
On behalf of the board
Mr Daniel Faucitt
Director
10/10/2025
The notes on page 2 form part of these financial statements.
Page 1
Page 2
London International Inflammation Foundation Limited
Notes to the Financial Statements
For The Year Ended 30 September 2025
Notes to the Financial Statements
1.General Information
London International Inflammation Foundation Limited is a private company, limited by guarantee, incorporated in England & Wales, registered number 08704252. The registered office is C/O Goringe Accountants Ltd, Waterside, 1650 Arlington Business Park, Reading, Berkshire, RG7 4SA.
2.Accounting Policies
2.1.Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3.Average Number of Employees
Average number of employees, including directors, during the year was: (2024: )
--
4.Company limited by guarantee
The company is limited by guarantee and has no share capital.
Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £1.